EC31 inhibited the efflux activity of P-gp, restored intracellular or intratumor drug accumulation, and eventually chemosensitized the P-gp-overexpressing cells or xenograft and the leukemia cancers to the anticancer drug again. Here, PGP is linked to leukemia.